| Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double … JS Heier, AM Khanani, CQ Ruiz, K Basu, PJ Ferrone, C Brittain, ... The Lancet 399 (10326), 729-740, 2022 | 268 | 2022 |
| Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two … CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ... The Lancet 399 (10326), 741-755, 2022 | 247 | 2022 |
| Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study Y Ogura, J Roider, JF Korobelnik, FG Holz, C Simader, U Schmidt-Erfurth, ... American journal of ophthalmology 158 (5), 1032-1038. e2, 2014 | 189 | 2014 |
| Expert opinion on management of intraocular inflammation, retinal vasculitis, and vascular occlusion after brolucizumab treatment CR Baumal, B Bodaghi, M Singer, DJ Tanzer, A Seres, MR Joshi, ... Ophthalmology Retina 5 (6), 519-527, 2021 | 124 | 2021 |
| Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study ML Ribeiro, AI Seres, AM Carneiro, M Stur, A Zourdani, P Caillon, ... Graefe's archive for clinical and experimental ophthalmology 244, 1591-1600, 2006 | 122 | 2006 |
| The SECURE study: long-term safety of ranibizumab 0.5 mg in neovascular age-related macular degeneration R Silva, R Axer-Siegel, B Eldem, R Guymer, B Kirchhof, A Papp, A Seres, ... Ophthalmology 120 (1), 130-139, 2013 | 116 | 2013 |
| Clinical characteristics and outcomes of eyes with intraocular inflammation after brolucizumab: post hoc analysis of HAWK and HARRIER M Singer, TA Albini, A Seres, CR Baumal, S Parikh, R Gale, PK Kaiser, ... Ophthalmology retina 6 (2), 97-108, 2022 | 51 | 2022 |
| Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial AM Khanani, SS Patel, G Staurenghi, R Tadayoni, CJ Danzig, ... The Lancet 402 (10411), 1449-1458, 2023 | 41 | 2023 |
| Vogt–Koyanagi–Harada disease presenting initially as aseptic meningoencephalitis A Kamondi, A Szegedi, A Papp, A Seres, I Szirmai European Journal of Neurology 7 (6), 719-722, 2000 | 32 | 2000 |
| The diameters of the human retinal branch vessels do not change in darkness G Barcsay, A Seres, J Németh Investigative ophthalmology & visual science 44 (7), 3115-3118, 2003 | 27 | 2003 |
| Vision-related quality of life in patients with diabetic macular edema treated with intravitreal aflibercept: the AQUA study JG Garweg, J Stefanickova, C Hoyng, T Schmelter, T Niesen, O Sowade, ... Ophthalmology Retina 3 (7), 567-575, 2019 | 22 | 2019 |
| Photodynamic (verteporfin) therapy for retinal capillary haemangioma, with monitoring of feeder and draining blood vessel diameters A Szabó, Z Géhl, A Seres Acta Ophthalmologica Scandinavica 83 (4), 512-513, 2005 | 21 | 2005 |
| Central corneal thickness measurements with optical coherence tomography and ultrasound pachymetry in healthy subjects and in patients after photorefractive keratectomy M Schneider, G Borgulya, A Seres, ZZ Nagy, J Nemeth European Journal of Ophthalmology 19 (2), 180-187, 2009 | 13 | 2009 |
| Presentation delay in patients affected with exudative age-related macular degeneration WM Haddad, A Seres, G Coscas, G Soubrane Graefe's archive for clinical and experimental ophthalmology 240, 31-34, 2002 | 11 | 2002 |
| BALATON and COMINO: phase III randomized clinical trials of faricimab for retinal vein occlusion: study design and rationale LO Hattenbach, F Abreu, P Arrisi, K Basu, CJ Danzig, R Guymer, ... Ophthalmology Science 3 (3), 100302, 2023 | 9 | 2023 |
| Boundary detection errors on optical coherence tomography images in patients with diabetic retinopathy M Schneider, A Seres, G Borgulya, J Nemeth Ophthalmic Surgery, Lasers and Imaging Retina 41 (1), 54-59, 2010 | 6 | 2010 |
| Unexpected ametropia after intraocular lens implantation: the role of different factors of ultrasound biometry and surgery A Seres, J Németh, I Süveges Ultrasonography in Ophthalmology XV: Proceedings of the 15th SIDUO Congress …, 1997 | 5 | 1997 |
| Suggested terminology for different phases of indocyanine green angiogram G Soubrane, A Seres, G Coscas Retina 20 (3), 319, 2000 | 4 | 2000 |
| TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2 AM Khanani, A Kotecha, A Chang, SJ Chen, Y Chen, R Guymer, JS Heier, ... Ophthalmology, 2024 | 2 | 2024 |
| Photodynamic therapy in age-related macular degeneration A Seres, A Papp, I Süveges Orvosi Hetilap 146 (42), 2143-2149, 2005 | 2 | 2005 |
Janos NemethProfessor of Ophthalmology, Semmelweis UniversityПотвърден имейл адрес: med.semmelweis-univ.hu
